6378 related articles for article (PubMed ID: 3123559)
1. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
Akutsu Y; Jimbow K
J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma.
Akutsu Y; Jimbow K
Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387
[TBL] [Abstract][Full Text] [Related]
3. A murine monoclonal antibody, MoAb HMSA-5, against a melanosomal component highly expressed in early stages, and common to normal and neoplastic melanocytes.
Der JE; Dixon WT; Jimbow K; Horikoshi T
Br J Cancer; 1993 Jan; 67(1):47-57. PubMed ID: 7678981
[TBL] [Abstract][Full Text] [Related]
4. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
Maeda K; Jimbow K
Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
[TBL] [Abstract][Full Text] [Related]
5. Development of MoAb HMSA-3 and HMSA-4 against human melanoma melanosomes and their reactivities on formalin-fixed melanoma tissues.
Maeda K; Yamana K; Jimbow K
J Invest Dermatol; 1987 Dec; 89(6):588-93. PubMed ID: 3680982
[TBL] [Abstract][Full Text] [Related]
6. Nature and biosynthesis of structural matrix protein in melanosomes: melanosomal structural protein as differentiation antigen for neoplastic melanocytes.
Jimbow K; Yamana K; Akutsu Y; Maeda K
Prog Clin Biol Res; 1988; 256():169-82. PubMed ID: 3368488
[TBL] [Abstract][Full Text] [Related]
7. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
Maeda K; Maeda K; Jimbow K
J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a human melanosome-associated antigen recognized by monoclonal antibody, HMSA-2.
Maeda K; Dixon WT; Jerry LM
J Invest Dermatol; 1990 Feb; 94(2):221-6. PubMed ID: 2405066
[TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
Yamamoto H; Takeuchi T
J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
[TBL] [Abstract][Full Text] [Related]
10. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
11. Complementary expression of melanosomal antigens and constant expression of pigment-independent antigen during the evolution of melanocytic tumours.
Takahashi H; Parsons PG; Favier D; McEwan M; Strutton GM; Akutsu Y; Jimbow K
Virchows Arch A Pathol Anat Histopathol; 1990; 416(6):513-9. PubMed ID: 2110698
[TBL] [Abstract][Full Text] [Related]
12. Characterization of melanosome-associated proteins by establishment of monoclonal antibodies and immunoscreening of a melanoma cDNA library through an anti-melanosome antibody.
Dakour J; Jimbow K; Vinayagamoorthy T; Luo D; Chen H
Melanoma Res; 1993 Oct; 3(5):331-6. PubMed ID: 8292889
[TBL] [Abstract][Full Text] [Related]
13. Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma.
Maeda K; Maeda K; Jimbow K
Cancer; 1988 Sep; 62(5):926-34. PubMed ID: 3044572
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors.
Berrington AJ; Jimbow K; Haines DM
Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235
[TBL] [Abstract][Full Text] [Related]
15. Melanosomal antigenic expression on the cell surface and intracellular subunits within melanogenic compartments of pigment cells: analysis by antimelanosome-associated monoclonal antibody.
Hayashibe K; Mishima Y; Ichihashi M; Kawai M
J Invest Dermatol; 1986 Jul; 87(1):89-94. PubMed ID: 3522755
[TBL] [Abstract][Full Text] [Related]
16. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
Imokawa G; Mishima Y
Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
[TBL] [Abstract][Full Text] [Related]
17. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy.
Taatjes DJ; Arendash-Durand B; von Turkovich M; Trainer TD
Arch Pathol Lab Med; 1993 Mar; 117(3):264-8. PubMed ID: 8442672
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
[TBL] [Abstract][Full Text] [Related]
19. Origin of melanosome structures and cytochemical localizations of tyrosinase activity in differentiating epidermal melanocytes of newborn mouse skin.
Hirobe T
J Exp Zool; 1982 Dec; 224(3):355-63. PubMed ID: 6818322
[TBL] [Abstract][Full Text] [Related]
20. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
[Next] [New Search]